20160502 CCMG-CCGM - Platform Presentations Survey

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing
Jean-Baptiste Rivière

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia
Chelsea Lowther

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports
Val Lapin

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations
Alison Eaton

TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type
Inara Chacon

	Did Not Attend	Poor	Fair	Good	Very Good	Excellent
TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda	TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Did Not Attend	TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Poor	TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Fair	TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Good	TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Very Good	TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Excellent
TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia	TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Did Not Attend	TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Poor	TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Fair	TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Good	TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Very Good	TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Excellent
TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports	TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Did Not Attend	TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Poor	TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Fair	TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Good	TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Very Good	TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Excellent
TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations	TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Did Not Attend	TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Poor	TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Fair	TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Good	TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Very Good	TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Excellent
TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type	TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Did Not Attend	TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Poor	TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Fair	TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Good	TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Very Good	TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Excellent

Did Not Attend

Poor

Fair

Good

Very Good

Excellent

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Did Not Attend

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Poor

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Fair

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Good

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Very Good

TMG 202 Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommenda Excellent

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Did Not Attend

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Poor

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Fair

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Good

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Very Good

TMG 210 Delineating the impact of rare copy number variation on IQ in schizophrenia Excellent

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Did Not Attend

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Poor

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Fair

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Good

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Very Good

TMG 212 Exome reanalysis: Integration of new knowledge in genomic reports Excellent

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Did Not Attend

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Poor

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Fair

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Good

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Very Good

TMG 222 Investigation of simplex patients born to consanguineous parents: Whole exome sequencing has a high yield, with significant contribution of de novo mutations Excellent

TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type

TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Did Not Attend

TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Poor

TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Fair

TMG 217 Homozygous mutation in RSPRY1 in a patient of Canadian indigenous descent results in skeletal dysplasia and intellectual disability: Expanding the phenotype of SEMD Faden-Alkuraya type Good

	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning Strongly Disagree	Sufficient time was allowed for audience participation/active learning Disagree	Sufficient time was allowed for audience participation/active learning Neutral	Sufficient time was allowed for audience participation/active learning Agree	Sufficient time was allowed for audience participation/active learning Strongly Agree
The facilities were satisfactory	The facilities were satisfactory Strongly Disagree	The facilities were satisfactory Disagree	The facilities were satisfactory Neutral	The facilities were satisfactory Agree	The facilities were satisfactory Strongly Agree
The session was free from commercial bias	The session was free from commercial bias Strongly Disagree	The session was free from commercial bias Disagree	The session was free from commercial bias Neutral	The session was free from commercial bias Agree	The session was free from commercial bias Strongly Agree
Overall, I would rate this Symposium as excellent	Overall, I would rate this Symposium as excellent Strongly Disagree	Overall, I would rate this Symposium as excellent Disagree	Overall, I would rate this Symposium as excellent Neutral	Overall, I would rate this Symposium as excellent Agree	Overall, I would rate this Symposium as excellent Strongly Agree

Strongly Disagree

Disagree

Neutral

Agree

Strongly Agree

Sufficient time was allowed for audience participation/active learning

Sufficient time was allowed for audience participation/active learning Strongly Disagree

Sufficient time was allowed for audience participation/active learning Disagree

Sufficient time was allowed for audience participation/active learning Neutral

Sufficient time was allowed for audience participation/active learning Agree

Sufficient time was allowed for audience participation/active learning Strongly Agree

The facilities were satisfactory

The facilities were satisfactory Strongly Disagree

The facilities were satisfactory Disagree

The facilities were satisfactory Neutral

The facilities were satisfactory Agree

The facilities were satisfactory Strongly Agree

The session was free from commercial bias

The session was free from commercial bias Strongly Disagree

The session was free from commercial bias Disagree

The session was free from commercial bias Neutral

The session was free from commercial bias Agree

The session was free from commercial bias Strongly Agree

Overall, I would rate this Symposium as excellent

Overall, I would rate this Symposium as excellent Strongly Disagree

Overall, I would rate this Symposium as excellent Disagree

Overall, I would rate this Symposium as excellent Neutral

Overall, I would rate this Symposium as excellent Agree

Overall, I would rate this Symposium as excellent Strongly Agree

20160502 CCMG-CCGM - Platform Presentations

Platform Presentations by abstract authors

Question Title

* 1. Please Rate Each Session:

Question Title

* 2. Please assess the Sessions as a whole

Question Title

* 3. As a result of attending these sessions, I am planning to:

Question Title

* 4. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 5. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Question Title

* 6. General comments about individual speakers:

Question Title

* 7. What topics would you like to be addressed at future conferences to keep you up to date in your profession?